Tandem Diabetes Care (TNDM)
(Delayed Data from NSDQ)
$44.64 USD
-0.80 (-1.76%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $44.80 +0.16 (0.36%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 29% (72 out of 252)Zacks Sector Rank
Top 38% (6 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.72 | 1.66 | 9.99 |
Current Quarter Estimate | -0.43 | 4.85 | 61.00 |
Year Ago Quarter Estimate | -0.38 | 3.52 | 54.84 |
Next Quarter Estimate | -0.21 | 5.65 | 63.00 |
Next Year Estimate | -1.18 | 24.56 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -12.10 | 12.50 | 15.67 |
Next Year | 32.95 | 20.50 | 11.34 |
Last 5 Years | NA | 10.20 | 8.10 |
Next 5 Years | NA | 13.40 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 7.07 |
Price/Book (MRQ) | 12.72 | 2.40 |
Price/Cash Flow (MRFY) | NA | 19.09 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -17.15% | -27.83% |
Return on Equity (TTM) | -41.54% | -23.39% |
Debt to Equity (MRQ) | 1.31 | 8.83 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.